Over The Counter Drugs Market

Europe Over The Counter Drugs Market by Product Types (Cough, Cold & Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral & Supplements, Weight-loss/Dietary Products, Ophthalmic Products, Sleeping Aids, and Others), Distribution Channels (Hospital Pharmacies, Online Pharmacy, Retail Pharmacies, and Others), and Geography (France, United Kingdom, Italy, Germany, Spain, and Rest of Europe) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-1998
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 183
  • Format:
  • Pub. Date: Upcoming
  • Share:

The Europe over the counter drugs market size is expected to expand at a high CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing expenditure on over-the-counter drugs in European countries as an affordable treatment option and increasing awareness of self-care.

Europe Over The Counter Drugs Market key takeaways

Over-the-counter drugs are medicines that can be purchased without a prescription and are safe and effective when used as directed. They usually contain various medicines used to relieve pain and itching and some common symptoms, including colds, body aches, allergies and flu, heartburn, acne, and other serious health problems. OTC drugs are safe and well tolerated. These products can be purchased in hospital pharmacies, medical supply stores, and sometimes even retail stores, and can be legally sold without a prescription. Self-medication is one of the key factors for market growth during the forecast period. According to pharmacological epidemiology and drug safety data, approximately 20.0% of the total population of Spain relies on over-the-counter drugs.

The Covid-19 pandemic affected the demand and supply of Europe over the counter drugs market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.

Market Trends, Drivers, Restraints, and Opportunities

  • Increasing self-medication trend and adoption of over the counter drugs is expected to boost the market during the forecast period.
  • Rapid growth of the pharmaceutical industry owing to innovation of over the counter drugs and increasing demand from consumers is major factors fueling the market during the forecast period.
  • Rising cases of chronic diseases and availability & accessibility of over the counter products is anticipated to drive the market during forecast period.
  • High risk of wrong medication and side effects due to self-medications is projected to hamper the market growth.
  • Lack of awareness about drug and strict government regulation on preventing the use of specific drugs act as major factors that restrict the market growth during the forecast period.
  • R&D investment and innovation of new OTC products with broad portfolio of medicines and minimum side effects is expected to offer significant opportunities for the market players.

Scope of the Report

The report on the Europe over the counter drugs market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Europe Over the Counter Drugs Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Product Types (Cough, Cold & Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral & Supplements, Weight-loss/Dietary Products, Ophthalmic Products, Sleeping Aids, and Others), and Distribution Channels (Hospital, Pharmacies, Online Pharmacy, Retail Pharmacies, and Others)

Geography

United Kingdom, France, Italy, Germany, Spain, Rest of Europe

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Cardinal Health Inc.; GlaxoSmithKline PLC; Astra Zeneca PLC; Johnson & Johnson; and Bayer AG

 

Market Segment Insights

The cough, cold & flu products segment is projected to hold a major market share

In terms of product types, the Europe over the counter drugs market is segregated into analgesics, dermatology products, cough, cold & flu products, gastrointestinal products, vitamins, mineral & supplements, ophthalmic products, sleeping aids, weight-loss/dietary products, and others. The cough, cold & flu products segment is expected to hold a key share of the market during the forecast period owing. In addition, the recent COVID19 pandemic has led to a strong demand for over-the-counter medicines to treat virus-related common symptoms such as flu, colds, and coughs. In addition, market participants frequently launch new products to gain a competitive advantage in the market. The increasing prevalence of these common diseases (such as cough, cold and flu) in the aging population has prompted patients to use more over-the-counter drugs because these drugs are easily available and widely used. They can be purchased without a prescription. This saves time and money for doctor and hospital visits. Consumers are increasingly relying on over-the-counter cough and cold medicines as the first response for rapid symptom relief. On the other hand, the vitamins, minerals & supplements segment is anticipated to expand at a rapid pace during the forecast period. Strong demand from athletes and professionals for energy products and dietary supplements for weight management is driving the market. According to the survey conducted by the committee on responsible nutrition in 2019, it was found that vitamins and minerals are the most commonly consumed nutritional supplement category. Over-the-counter drugs for these situations are more preventive than treatment.

Europe Over The Counter Drugs Market by product types

The retail pharmacies segment is expected to grow at a rapid pace

Based on distribution channels, the Europe over the counter drugs market is fragmented into hospital, pharmacies, online pharmacy, retail pharmacies, and others. The retail pharmacies segment is projected to hold a key share of the market during the forecast period due to increasing number of retail pharmacies offering OTC products and growing patient preference for these products in retail stores and pharmacies, the retail pharmacy and pharmacy segment is expected to hold major market share during the forecast period.

Europe Over The Counter Drugs Market by distribution channels

 Germany is anticipated to dominate the market

On the basis of regions, the Europe over the counter drug market is categorized as United Kingdom, France, Italy, Germany, Spain, and Rest of Europe. Germany is anticipated to dominate the market during the forecast period. Germany is the largest market in Europe, with a market share of 22%. While developing countries such as UK are showing growth mainly due to insufficient penetration rates due to the widespread use of self-medication and the presence of non-prescription drug companies in the region. The high CAGR is due to changing consumer attitudes towards self-medication, increasing elderly population, and rapid shift from prescription-only drugs to over-the-counter drugs and availability of over-the-counter medicines. In addition, the existence of pharmaceutical companies such as GlaxoSmithKline, Procter & Gamble in the region is driving the market.

Segments

Segments Covered in the Report
The Europe over the counter drugs market has been segmented on the basis of

Product Types

  • Cough, Cold & Flu Products
  • Analgesics
  • Dermatology Products
  • Gastrointestinal Products
  • Vitamins, Mineral & Supplements
  • Weight-loss/Dietary Products
  • Ophthalmic Products
  • Sleeping Aids
  • Others

Distribution Channels

  • Hospital
  • Pharmacies
  • Online Pharmacy
  • Retail Pharmacies
  • Others

Geography

  • United Kingdom
  • Spain
  • Italy
  • France
  • Germany
  • Rest of Europe

Key Players

  • Cardinal Health Inc.
  • GlaxoSmithKline PLC
  • Astra Zeneca PLC
  • Johnson & Johnson
  • Bayer AG

Competitive Landscape

Key players competing in the Europe over the counter drugs market include Cardinal Health Inc.; GlaxoSmithKline PLC; Astra Zeneca PLC; Johnson & Johnson; and Bayer AG.

Some of these players are using several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.
 

Europe Over The Counter Drugs Market by key players
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Over The Counter Drugs Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Over The Counter Drugs Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Over The Counter Drugs Market - Supply Chain
  4.5. Global Over The Counter Drugs Market Forecast
     4.5.1. Over The Counter Drugs Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Over The Counter Drugs Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Over The Counter Drugs Market Absolute $ Opportunity
5. Global Over The Counter Drugs Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Over The Counter Drugs Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Over The Counter Drugs Demand Share Forecast, 2019-2026
6. North America Over The Counter Drugs Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Over The Counter Drugs Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Over The Counter Drugs Demand Share Forecast, 2019-2026
7. Latin America Over The Counter Drugs Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Over The Counter Drugs Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Over The Counter Drugs Demand Share Forecast, 2019-2026
8. Europe Over The Counter Drugs Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Over The Counter Drugs Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Over The Counter Drugs Demand Share Forecast, 2019-2026
9. Asia Pacific Over The Counter Drugs Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Over The Counter Drugs Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Over The Counter Drugs Demand Share Forecast, 2019-2026
10. Middle East & Africa Over The Counter Drugs Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Over The Counter Drugs Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Over The Counter Drugs Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Over The Counter Drugs Market: Market Share Analysis
  11.2. Over The Counter Drugs Distributors and Customers
  11.3. Over The Counter Drugs Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Cardinal Health Inc.
     11.4.2. GlaxoSmithKline PLC
     11.4.3. Astra Zeneca PLC
     11.4.4. Johnson & Johnson
     11.4.5. Bayer AG

Segments Covered in the Report
The Europe over the counter drugs market has been segmented on the basis of

Product Types

  • Cough, Cold & Flu Products
  • Analgesics
  • Dermatology Products
  • Gastrointestinal Products
  • Vitamins, Mineral & Supplements
  • Weight-loss/Dietary Products
  • Ophthalmic Products
  • Sleeping Aids
  • Others

Distribution Channels

  • Hospital
  • Pharmacies
  • Online Pharmacy
  • Retail Pharmacies
  • Others

Geography

  • United Kingdom
  • Spain
  • Italy
  • France
  • Germany
  • Rest of Europe

Key Players

  • Cardinal Health Inc.
  • GlaxoSmithKline PLC
  • Astra Zeneca PLC
  • Johnson & Johnson
  • Bayer AG

Key players competing in the Europe over the counter drugs market include Cardinal Health Inc.; GlaxoSmithKline PLC; Astra Zeneca PLC; Johnson & Johnson; and Bayer AG.

Some of these players are using several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.
 

Europe Over The Counter Drugs Market by key players

Buy Report